Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125801193 | 12580119 | 3 | F | 2015 | 20160906 | 20160721 | 20160914 | EXP | JP-ASTRAZENECA-2016SE78156 | ASTRAZENECA | 53.00 | YR | F | Y | 0.00000 | 20160914 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125801193 | 12580119 | 1 | PS | QUETIAPINE. | QUETIAPINE | 1 | Oral | 4575 | MG | U | 20639 | 75 | MG | TABLET | QD | ||||
| 125801193 | 12580119 | 2 | SS | TIAPRIDE | TIAPRIDE | 1 | Unknown | 50-150 MG ONCE DAILY | U | U | 0 | ||||||||
| 125801193 | 12580119 | 3 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 5 TO 10 MG DAILY | U | U | 0 | ||||||||
| 125801193 | 12580119 | 4 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 5 TO 10 MG DAILY | U | U | 0 | ||||||||
| 125801193 | 12580119 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 122 | MG | U | 0 | 2 | MG | QD | |||||
| 125801193 | 12580119 | 6 | SS | BIPERIDEN | BIPERIDEN | 1 | Oral | U | U | 0 | 2 | MG | QD | ||||||
| 125801193 | 12580119 | 7 | SS | BIPERIDEN | BIPERIDEN | 1 | Oral | U | U | 0 | 3 | MG | QD | ||||||
| 125801193 | 12580119 | 8 | SS | BIPERIDEN | BIPERIDEN | 1 | Oral | U | U | 0 | 6 | MG | QD | ||||||
| 125801193 | 12580119 | 9 | SS | BIPERIDEN | BIPERIDEN | 1 | Oral | U | U | 0 | 3 | MG | QD | ||||||
| 125801193 | 12580119 | 10 | C | LEVODOPA-CARBIDOPA | CARBIDOPALEVODOPA | 1 | Oral | 0 | |||||||||||
| 125801193 | 12580119 | 11 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0 | |||||||||||
| 125801193 | 12580119 | 12 | C | BROTIZOLAM | BROTIZOLAM | 1 | Oral | 0 | |||||||||||
| 125801193 | 12580119 | 13 | C | YOKUKANSAN | HERBALS | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125801193 | 12580119 | 1 | Product used for unknown indication |
| 125801193 | 12580119 | 2 | Dementia with Lewy bodies |
| 125801193 | 12580119 | 3 | Product used for unknown indication |
| 125801193 | 12580119 | 4 | Product used for unknown indication |
| 125801193 | 12580119 | 5 | Product used for unknown indication |
| 125801193 | 12580119 | 6 | Parkinsonism |
| 125801193 | 12580119 | 7 | Parkinsonism |
| 125801193 | 12580119 | 8 | Parkinsonism |
| 125801193 | 12580119 | 9 | Parkinsonism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125801193 | 12580119 | OT |
| 125801193 | 12580119 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125801193 | 12580119 | Drug hypersensitivity | |
| 125801193 | 12580119 | Neuroleptic malignant syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125801193 | 12580119 | 1 | 2013 | 2013 | 0 | |
| 125801193 | 12580119 | 3 | 2013 | 2013 | 0 | |
| 125801193 | 12580119 | 4 | 2013 | 2013 | 0 | |
| 125801193 | 12580119 | 5 | 2013 | 2013 | 0 | |
| 125801193 | 12580119 | 6 | 2013 | 2013 | 0 | |
| 125801193 | 12580119 | 7 | 2013 | 2013 | 0 | |
| 125801193 | 12580119 | 8 | 2013 | 2013 | 0 | |
| 125801193 | 12580119 | 9 | 2015 | 0 | ||
| 125801193 | 12580119 | 10 | 201309 | 2015 | 0 |